Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jamie Friedman

Sports Medicine Aurora, CO Medical Doctor

NPI 1710398177 CMS profile 6264480

12605 E 16Th Ave, Aurora, CO 80045

Open in the dashboard

General payments

$39,653

78 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jamie Friedman of Aurora, CO is reported in the CMS Open Payments database as having received $39,653 across 78 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,613 17
2024 General $1,534 20
2023 General $1,258 20
2022 General $1,834 4
2021 General $2,678 5
2020 General $9,351 5
2019 General $21,385 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jamie Friedman
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Jamie Friedman were reported at $1,613. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Jamie Friedman Sports Medicine median Middle half National median
2019 $21,385 $1,176 $199–$4,249 $163
2020 $9,351 $708 $96–$2,890 $114
2021 $2,678 $1,213 $152–$3,994 $132
2022 $1,834 $1,230 $159–$3,998 $149
2023 $1,258 $584 $146–$2,836 $160
2024 $1,534 $628 $163–$3,168 $164
2025 $1,613 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $23,536 43 payments
  2. Gemini Mountain Medical, LLC $7,871 12 payments
  3. Smith+Nephew, Inc. $6,693 7 payments
  4. Stryker Corporation $560 6 payments
  5. Encore Medical, LP $506 4 payments
  6. Alliance Medical $232 3 payments
  7. Ossur Americas., Inc $199 1 payment
  8. Zimmer Biomet Holdings, Inc. $57 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $20,000 1 payment
  2. Education $13,563 7 payments
  3. Travel and Lodging $3,171 10 payments
  4. Food and Beverage $2,920 60 payments
Products named General payments · program years 2019–2025
  1. Bioinductive Implant with Arthroscopic Delivery System - Medium $293 5 payments
  2. MAKO $284 3 payments
  3. DJO SURGICAL Joint Implants $266 2 payments
  4. Miami J $199 1 payment
  5. HEALICOIL PK Shoulder $150 1 payment
  6. MULTIFIX System $150 1 payment
  7. DJO SURGICAL Joint Implants $150 1 payment
  8. HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET $129 1 payment
  9. CHAMPION SHOULDER INSTRUMENTATION SET $120 1 payment
  10. DJO Surgical Alians Proximal Humerus Fracture Plate $90 1 payment
  11. Other $436 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

366

Median for Sports Medicine: 144

Drug cost

$2,764

Median for Sports Medicine: $1,027

Branded share of claims

26%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ondansetron Odt Ondansetron Brand 95 $1,040
Oxycodone Hcl Generic 97 $827
Diclofenac Sodium Generic 42 $521
Naproxen Generic 97 $283
Tramadol Hcl Generic 12 $58
Meloxicam Generic 23 $36

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$146,789

Of which drugs: $9,494

Medicare patients

245

Average age 72

Services billed

2,010

168 women, 77 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 60%
Depression 24%
Diabetes 20%
Ischemic heart disease 20%
Osteoporosis 18%
Chronic kidney disease 16%
Cancer 11%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose J7326 Office 15 22 $8,873
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 95 888 $621

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

78 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record